Outstanding presentation on trial of AZA + Ven in younger #AMLsm adults by @DanPollyea #ASH24. Proud to be part of this collaboration @SylvesterCancer @UMiamiHealth! ORR 69%, MRD- 64% @ash-hematology.bsky.social
Comments
Log in with your Bluesky account to leave a comment
Comments